Go to virtual 3D site

Sponsor: Pelago Bioscience AB

Pelago Bioscience AB
Where: 10
The CEllular Thermal Shift Assay (CETSA) allows a direct quantification of drug target engagement in living cells and tissues. The biophysical basis of the method enables a label free approach on the native endogenously expressed target in situ. Because of the generic format and the physiological relevance of CETSA, Pelago Bioscience has implemented multiple applications in Drug Discovery. Since the first publication of the CETSA method it has been used for orthogonal measures of drug occupancy adding real value to existing efficacy assays on more than 70 drug targets in multiple therapy areas. The examples of CETSA utility ranges from Target ID and validation, lead generation and drug candidate profiling to translational science and rational biomarker discovery.
Tel: +46(0)769410187
Address: Banvaktsvägen 20
171 48 Solna
Website: www.pelagobio.com
Email: info@pelagobio.com

Presentations at Research & Innovation 2021

Staff Attending

Mr Joakim Grånemo
Business Development Manager
Pelago Bioscience AB
Dr Daniel Martinez Molina
Pelago Bioscience AB

Hosted By

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Follow us on Twitter

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
Eventflo Home
copyright ELRIG, eventflo.co.uk, Labhoo Ltd 2003-2021